Immunohistochemical experiments were performed only in COVID-19 lung parenchyma for CD61 (megakaryocyte marker), CD68 (histiocytic marker), and Ki67 (proliferation index) to better characterize the cells with abnormal and irregular nuclei present in the lung interstitium. Here, CD68 is linked to COVID-19.